These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 17898004)
1. Hypocretin (orexin) and melanin concentrating hormone loss and the symptoms of Parkinson's disease. Thannickal TC; Lai YY; Siegel JM Brain; 2008 Jan; 131(Pt 1):e87. PubMed ID: 17898004 [No Abstract] [Full Text] [Related]
2. Hypocretin (orexin) cell loss in Parkinson's disease. Thannickal TC; Lai YY; Siegel JM Brain; 2007 Jun; 130(Pt 6):1586-95. PubMed ID: 17491094 [TBL] [Abstract][Full Text] [Related]
3. Reduced number of hypocretin neurons in human narcolepsy. Thannickal TC; Moore RY; Nienhuis R; Ramanathan L; Gulyani S; Aldrich M; Cornford M; Siegel JM Neuron; 2000 Sep; 27(3):469-74. PubMed ID: 11055430 [TBL] [Abstract][Full Text] [Related]
4. Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness? Wienecke M; Werth E; Poryazova R; Baumann-Vogel H; Bassetti CL; Weller M; Waldvogel D; Storch A; Baumann CR J Sleep Res; 2012 Dec; 21(6):710-7. PubMed ID: 22747735 [TBL] [Abstract][Full Text] [Related]
5. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy. Thannickal TC; Nienhuis R; Siegel JM Sleep; 2009 Aug; 32(8):993-8. PubMed ID: 19725250 [TBL] [Abstract][Full Text] [Related]
6. Increase of histaminergic tuberomammillary neurons in narcolepsy. Valko PO; Gavrilov YV; Yamamoto M; Reddy H; Haybaeck J; Mignot E; Baumann CR; Scammell TE Ann Neurol; 2013 Dec; 74(6):794-804. PubMed ID: 24006291 [TBL] [Abstract][Full Text] [Related]
7. The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance. Georgescu D; Sears RM; Hommel JD; Barrot M; Bolaños CA; Marsh DJ; Bednarek MA; Bibb JA; Maratos-Flier E; Nestler EJ; DiLeone RJ J Neurosci; 2005 Mar; 25(11):2933-40. PubMed ID: 15772353 [TBL] [Abstract][Full Text] [Related]
8. Regulation of synaptic efficacy in hypocretin/orexin-containing neurons by melanin concentrating hormone in the lateral hypothalamus. Rao Y; Lu M; Ge F; Marsh DJ; Qian S; Wang AH; Picciotto MR; Gao XB J Neurosci; 2008 Sep; 28(37):9101-10. PubMed ID: 18784290 [TBL] [Abstract][Full Text] [Related]
9. Relation of melanin concentrating hormone levels to sleep, emotion and hypocretin levels. Blouin AM; Siegel JM Sleep; 2013 Dec; 36(12):1777. PubMed ID: 24293749 [No Abstract] [Full Text] [Related]
10. Hypothalamic cocaine- and amphetamine-regulated transcript (CART) neurons: histochemical relationship to thyrotropin-releasing hormone, melanin-concentrating hormone, orexin/hypocretin and neuropeptide Y. Broberger C Brain Res; 1999 Nov; 848(1-2):101-13. PubMed ID: 10612702 [TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y, but not agouti-related peptide or melanin-concentrating hormone, is a target peptide for orexin-A feeding actions in the rat hypothalamus. López M; Seoane LM; García Mdel C; Diéguez C; Señarís R Neuroendocrinology; 2002 Jan; 75(1):34-44. PubMed ID: 11810033 [TBL] [Abstract][Full Text] [Related]
12. Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy. Blouin AM; Thannickal TC; Worley PF; Baraban JM; Reti IM; Siegel JM Neurology; 2005 Oct; 65(8):1189-92. PubMed ID: 16135770 [TBL] [Abstract][Full Text] [Related]
13. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. Broberger C; De Lecea L; Sutcliffe JG; Hökfelt T J Comp Neurol; 1998 Dec; 402(4):460-74. PubMed ID: 9862321 [TBL] [Abstract][Full Text] [Related]
14. Excitotoxic degeneration of hypothalamic orexin neurons in slice culture. Katsuki H; Akaike A Neurobiol Dis; 2004 Feb; 15(1):61-9. PubMed ID: 14751771 [TBL] [Abstract][Full Text] [Related]
15. [A role for orexins and melanin-concentrating hormone in the central regulation of feeding behavior]. Date Y; Nakazato M; Matsukura S Nihon Rinsho; 2001 Mar; 59(3):427-30. PubMed ID: 11268588 [TBL] [Abstract][Full Text] [Related]
16. Distribution of hypothalamic neurons with orexin (hypocretin) or melanin concentrating hormone (MCH) immunoreactivity and multisynaptic connections with diaphragm motoneurons. Badami VM; Rice CD; Lois JH; Madrecha J; Yates BJ Brain Res; 2010 Apr; 1323():119-26. PubMed ID: 20144885 [TBL] [Abstract][Full Text] [Related]
17. Hypocretin (orexin) loss and sleep disturbances in Parkinson's Disease. Fronczek R; Overeem S; Lee SY; Hegeman IM; van Pelt J; van Duinen SG; Lammers GJ; Swaab DF Brain; 2008 Jan; 131(Pt 1):e88. PubMed ID: 17898003 [No Abstract] [Full Text] [Related]
18. Hypocretin and melanin-concentrating hormone in patients with Huntington disease. Aziz A; Fronczek R; Maat-Schieman M; Unmehopa U; Roelandse F; Overeem S; van Duinen S; Lammers GJ; Swaab D; Roos R Brain Pathol; 2008 Oct; 18(4):474-83. PubMed ID: 18498421 [TBL] [Abstract][Full Text] [Related]
19. Cannabinoids excite hypothalamic melanin-concentrating hormone but inhibit hypocretin/orexin neurons: implications for cannabinoid actions on food intake and cognitive arousal. Huang H; Acuna-Goycolea C; Li Y; Cheng HM; Obrietan K; van den Pol AN J Neurosci; 2007 May; 27(18):4870-81. PubMed ID: 17475795 [TBL] [Abstract][Full Text] [Related]
20. Interactions of neuropeptide Y, hypocretin-I (orexin A) and melanin-concentrating hormone on feeding in rats. Sahu A Brain Res; 2002 Jul; 944(1-2):232-8. PubMed ID: 12106685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]